| | Title | Author(s) | Year | View Count | | 1 |  | Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay | Seto, WK; Tanaka, Y; Wong, DKH; Lai, CL; Shinkai, N; Yuen, JCH; Tong, T; Fung, J; Hung, IFN; Yuen, MF | 2013 | 76 |
| 2 |  | HLA-DP and IL28 polymorphisms: Influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B | Seto, WKW; Wong, DKH; Kopaniszen, M; Proitsi, P; Sham, PC; Hung, IFN; Fung, JYY; Lai, CL; Yuen, RMF | 2013 | 26 |
| 3 | | Reduction of hepatitis B surface antigen levels and HBsAg seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy | Seto, WKW; Wong, DKH; Fung, JYY; Huang, FY; Lai, CL; Yuen, RMF | 2013 | 10 |
| 4 | | Outcome of lamivudine-resistant chronic hepatitis B after up to 5 years of combination therapy with adefovir | Seto, WK; Liu, K; Fung, J; Wong, DKH; Yuen, JCH; Hung, IFN; Lai, CL; Yuen, MF | 2012 | 76 |
| 5 | | Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B | Ahn, SH; Kweon, YO; Paik, SW; Sohn, JH; Lee, KS; Kim, DJ; Piratvisuth, T; Yuen, MF; Chutaputti, A; Chao, YC; Trylesinski, A; Avila, C | 2012 | 88 |
| 6 | | Rare inborn errors associated with chronic hepatitis B virus infection | Zhao, Q; Peng, L; Huang, W; Li, Q; Pei, Y; Yuan, P; Zheng, L; Zhang, Y; Deng, J; Zhong, C; Hu, B; Ding, H; Fang, W; Li, R; Liao, Q; Lin, C; Deng, W; Yan, H; Hou, J; Wu, Q; Xu, T; Liu, J; Hu, L; Peng, T; Chen, S; Lai, KN; Yuen, MF; Wang, Y; Maini, MK; Li, C; Li, M; Wang, J; Zhang, X; Sham, PC; Wang, J; Gao, ZL; Wang, Y | 2012 | 82 |
| 7 |  | A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B | Seto, WK; Lai, CL; Ip, PPC; Fung, J; Wong, DKH; Yuen, JCH; Hung, IFN; Yuen, MF | 2012 | 109 |
| 8 | | Effectiveness of Chinese herbal medicine in treating liver fibrosis: A systematic review and meta-analysis of randomized controlled trials | Cheung, F; Feng, Y; Wang, N; Yuen, MF; Tong, Y; Wong, VT | 2012 | 82 |
| 9 | | Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1β activation of nitric oxide production in gastric cancer cells | Huang, FY; Chan, AOO; Rashid, A; Wong, DKH; Cho, CH; Yuen, MF | 2012 | 92 |
| 10 | | A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance | Seto, WK; Wong, DKH; Fung, J; Hung, IFN; Fong, DYT; Yuen, JCH; Tong, T; Lai, CL; Yuen, MF | 2012 | 83 |
| 11 | | High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B | Seto, WK; Wong, DKH; Fung, J; Ip, PPC; Yuen, JCH; Hung, IFN; Lai, CL; Yuen, MF | 2012 | 101 |
| 12 | | No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations. | Sawai, H; Nishida, N; Mbarek, H; Matsuda, K; Mawatari, Y; Yamaoka, M; Hige, S; Kang, JH; Abe, K; Mochida, S; Watanabe, M; Kurosaki, M; Asahina, Y; Izumi, N; Honda, M; Kaneko, S; Tanaka, E; Matsuura, K; Itoh, Y; Mita, E; Korenaga, M; Hno, K; Murawaki, Y; Hiasa, Y; Ide, T; Ito, K; Sugiyama, M; Ahn, SH; Han, KH; Park, JY; Yuen, RMF; Nakamura, Y; Tanaka, Y; Mizokami, M; Mizokami, M; Tokunaga, K | 2012 | 60 |
| 13 | | This is hepatitis - it is closer than you think. | Fung, JYY; Yuen, RMF | 2012 | 43 |
| 14 | | Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1β activation of nitric oxide production in gastric cancer cells. | Huang, FY; Chan, AOO; Rashid, A; Wong, DKH; Cho, CH; Yuen, RMF | 2012 | 61 |
| 15 | | Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy. | Lai, CL; Yuen, RMF | 2012 | 59 |
| 16 | | Acute-on-chronic liver failure in chronic hepatitis B | Seto, WK; Lai, CL; Yuen, MF | 2012 | 71 |
| 17 | | Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B | Seto, WKW; Wong, DKH; Fung, JYY; Hung, IFN; Yuen, JCH; Tong, T; Lai, CL; Yuen, RMF | 2012 | 12 |
| 18 | | Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma | Tung, EKK; Mak, CKM; Fatima, S; Lo, RCL; Zhao, H; Zhang, C; Dai, H; Poon, RTP; Yuen, MF; Lai, CL; Li, JJ; Luk, JMC; Ng, IOL | 2011 | 222 |
| 19 | | Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome | Seto, WK; Lai, CL; Fung, J; Wong, DKH; Yuen, JCH; Hung, IFN; Yuen, MF | 2011 | 211 |
| 20 | | Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection | Seto, WK; Yuen, MF; Fung, J; Lai, CL | 2011 | 358 |
|
